---
schema_version: "secwatch.filing_event.v1"
accession: "0001564590-22-014650"
form_type: "8-K"
ticker: "CALC"
cik: "0001534133"
company_name: "CalciMedica, Inc."
filed_at: "2022-04-18T23:59:59+00:00"
generated_at: "2026-06-26T06:53:55.168983+00:00"
event_type: "leadership"
sentiment: "neutral"
materiality_score: 0.35
calibrated_materiality_score: 0.35
confidence: "high"
source: SEC EDGAR
---

# Graybug Vision appoints Dirk Sauer to board; Gerald Cagle resigns as director

## Summary
- Gerald Cagle resigned as director and from Nominating and Governance Committee effective April 13, 2022; will remain as paid advisor.
- Dirk Sauer appointed to board to fill vacancy, will serve as Class I director, expected to stand for election at 2024 annual meeting.
- Sauer will chair newly formed Science and Innovation Committee; compensation includes $40k annual retainer, $4k committee fee, and 80,000 share option grant vesting over 3 years.
- Sauer brings 30+ years ophthalmic drug development experience, previously led Novartis Ophthalmology Development Unit.

## SEC filing metadata
- accession: 0001564590-22-014650
- form_type: 8-K
- ticker: CALC
- cik: 0001534133
- company_name: CalciMedica, Inc.
- filed_at: 2022-04-18T23:59:59+00:00
- event_type: leadership
- sentiment: neutral
- materiality_score: 0.35
- calibrated_materiality_score: 0.35
- confidence: high
- sec_items: 5.02, 7.01, 9.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1534133/000156459022014650/0001564590-22-014650-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1534133/000156459022014650/gray-8k_20220413.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001564590-22-014650
- JSON: https://secwatch.observer/filing/0001564590-22-014650.json
- Plain text: https://secwatch.observer/filing/0001564590-22-014650.txt

## Key facts
- Executive change
  Gerald D. Cagle resigned as Director at CalciMedica, Inc..
  - Action: resigned
  - Role: Director
  source text: On April 13, 2022, the Board of Directors (the “Board”) of Graybug Vision, Inc. (the “Company”) received a letter from Gerald D. Cagle, Ph.D resigning as a director of the Company and as a member of the Nominating and Corporate Governance Committee of the Board, effective as of that day.
  evidence_url: https://www.sec.gov/Archives/edgar/data/1534133/000156459022014650/0001564590-22-014650-index.htm
- Executive change
  Dirk Sauer was appointed as Director at CalciMedica, Inc..
  - Action: appointed
  - Role: Director
  source text: On April 13, 2022 (the “Effective Date”) , the Board, upon the recommendation of the Nominating and Corporate Governance Committee of the Board, appointed Dirk Sauer, Ph.D, age 62, to serve as a member of the Board to fill the vacancy that was created by the resignation of Dr. Cagle described above.
  evidence_url: https://www.sec.gov/Archives/edgar/data/1534133/000156459022014650/0001564590-22-014650-index.htm

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.